- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Bill Gates Makes Major AIDS Donation
3 May 1999 6:00 pm
Microsoft CEO Bill Gates and his wife Melinda will announce tomorrow a $25 million contribution to the International AIDS Vaccine Initiative (IAVI), the largest single philanthropic donation ever made to AIDS research, Science has learned. "Bill and Melinda Gates are very excited and pleased to partner with organizations making such a difference in global health," confirms Trevor Neilson, a spokesperson for the William H. Gates Foundation.
IAVI will receive $5 million a year for the next 5 years from the foundation, which last June gave the New York-based nonprofit $1.5 million. According to Neilson, $13.5 million will fund up to three new international AIDS vaccine development teams. Another $3.5 million will support the two such teams put together last year to develop HIV vaccines specifically for Kenya and South Africa. Between $2.5 million and $3.5 million will go to IAVI's applied research program, advocacy and clinical trial preparation in developing countries, and operational support. "This historic act of generosity will allow us to significantly accelerate the scientific effort," says Seth Berkley, president of IAVI.
The new donation will more double IAVI's coffers to nearly $50 million and should significantly heighten the institute's ability to carry out development and human trials of these vaccines. The National Institutes of Health still remains by far the largest player in the field, now spending $200 million a year on HIV vaccine R&D. The iconoclastic IAVI, however, hopes to approach the problem from a novel angle, marrying academics from both wealthy and poor countries with cash-strapped companies.